A drug screening study conducted by the National Institute of Allergy and Infectious Diseases revealed that one of PanBiokem’s synthetic compounds (hereafter JKOR) demonstrated a dose dependent broadspectrum antiviral activity against a number of enveloped viruses, e.g., a coronavirus, influenza A and B viruses, respiratory virus, rhinovirus, measles virus, and a parainfluenza virus.
July 2, 2020
· 1 min read